Evidence map›Paper›PMID 28061953›Full record

ArticleTuberculosis (Edinburgh, Scotland)2017

Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international.

Carolina Geadas, Sonia K Stoszek, David Sherman, Bruno B Andrade, Sudha Srinivasan, Carol D Hamilton, Jerrold Ellner

Abstract readConference Proceedings
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carolina GeadasBoston Medical Center and Boston University School of Medicine, Department of Medicine, Section of Infectious Diseases, Boston, MA, USA.
Sonia K StoszekHealth Studies Sector, Westat, Rockville, MD, USA.
David ShermanCenter for Infectious Disease Research, Seattle, WA, USA.
Bruno B AndradeUnidade de Medicina Investigativa, Laboratório Integrado de Microbiologia e Imunorregulação, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Sudha SrinivasanDivision of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Carol D HamiltonScientific Affairs, Global Health, Population and Nutrition, FHI 360, Department of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA.
Jerrold EllnerBoston Medical Center and Boston University School of Medicine, Department of Medicine, Section of Infectious Diseases, Boston, MA, USA. Electronic address: Jerrold.Ellner@bmc.org.

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
Validation and Application of a Model for Human-like TB Latency in RabbitsU19AI111276 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI ALLAND, DAVID, HORN, DAVID LOUIS · 2014 to 2020
$23.3M
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contactsR01AI147765 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ANDRADE, BRUNO DE BEZERRIL, HAWN, THOMAS R · 2019 to 2023
$4.3M
NIAID NIH HHS P30 AI042853NIAID NIH HHS R01 AI147765NIAID NIH HHS U19 AI111276
6 · The paper itself

Abstract

RePORT International is a collaborative research network of investigators from multiple countries and institutions with the goal of establishing a bio-repository of specimens and clinical data for the study of active TB and latent TB infection (LTBI). During the first meeting of RePORT International in Boston, Massachusetts, the results of research pertinent to TB control and eradication were presented, including advances in the research of Mycobacterium tuberculosis (MTB) persistence and drug resistance, TB diagnostics, drug and vaccine development.

Indexed as

Antitubercular AgentsBiomedical ResearchDrug DiscoveryDrug Resistance, BacterialHumansMycobacterium tuberculosisTranslational Research, BiomedicalTuberculosisTuberculosis VaccinesAntitubercular AgentsTuberculosis VaccinesAdvancesRePORTResearchTuberculosis

Identifiers

PMID28061953
PMCPMC9067314

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.